What is Hybrent?
Hybrent operates as a specialized provider of supply chain management software tailored for the healthcare industry. The platform serves as a critical nexus for ambulatory surgery centers, physician offices, and critical access hospitals, offering a comprehensive suite of tools for purchasing, inventory management, and invoicing. By facilitating seamless integration with existing accounting and clinical applications, Hybrent enables healthcare organizations to optimize their procurement workflows. The software's core value proposition lies in its ability to drive cost reduction and operational efficiency through features such as automated ordering, comparison shopping, and actionable data analytics, effectively modernizing the back-office functions of medical facilities.
How much funding has Hybrent raised?
Hybrent has raised a total of $2.9M across 4 funding rounds:
Angel/Seed
$500K
Private Equity
$750K
Private Equity
$1.5M
Debt
$150K
Angel/Seed (2014): $500K, investors not publicly disclosed
Private Equity (2016): $750K, investors not publicly disclosed
Private Equity (2017): $1.5M, investors not publicly disclosed
Debt (2020): $150K featuring PPP
Key Investors in Hybrent
PPP
Public-Private Partnership
Undisclosed Investor
A private equity participant providing significant growth capital to scale enterprise-level healthcare software solutions.
Undisclosed Investor
An early-stage backer that provided the initial seed funding necessary to develop the core procurement platform.
What's next for Hybrent?
With the recent influx of capital, Hybrent is well-positioned to accelerate its product roadmap and expand its footprint in the healthcare supply chain ecosystem. The company is expected to focus on enhancing its integration capabilities and scaling its automated procurement tools to meet the increasing complexity of enterprise-level healthcare management. As the industry continues to prioritize cost-containment and digital transformation, Hybrent's strategic focus will likely center on deepening its market penetration among larger hospital networks and management groups. This phase of growth will be critical in establishing the company as a standard-bearer for efficiency in medical supply chain logistics, leveraging its data-driven insights to provide superior value to its expanding client base.
See full Hybrent company page
